Xeris Biopharma Holdings, Inc. (XERS) Return On Assets % [USD] 2022 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2022 to 2024.
  • Xeris Biopharma Holdings, Inc. Return On Assets for the quarter ending March 31, 2024 was -19.6 %, a 19% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Return On Assets for 2023 was -19.2 %, a 34.1% increase from 2022.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -19.6 +4.59 +19% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.2 +9.89 +34.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -18.7 +23.3 +55.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22 +28.1 +56% Apr 1, 2023 Jun 30, 2023
Q1 2023 -24.2 Jan 1, 2023 Mar 31, 2023
Q4 2022 -29 Oct 1, 2022 Dec 31, 2022
Q3 2022 -42 Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.1 Apr 1, 2022 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.